NanoLogix, Inc. (NNLX)
OTCMKTS · Delayed Price · Currency is USD
0.00008
0.00 (0.00%)
At close: Jul 10, 2026
NanoLogix Market Cap
NanoLogix has a market cap or net worth of $13.03 thousand as of July 23, 2026. Its market cap has decreased by -20.00% in one year.
Market Cap
13.03K
Enterprise Value
n/a
Revenue
1.27K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since June 18, 2003, NanoLogix's market cap has decreased from 696.05K to 13.03K, a decrease of -98.13%. That is a compound annual growth rate of -15.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 13.03K | 7,894.48% |
| Dec 27, 2023 | 163.00 | -99.00% |
| Dec 29, 2022 | 16.29K | 9,893.25% |
| Dec 30, 2021 | 163.00 | -100.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ocean Biomedical | 23.24K |
| Scopus BioPharma | 21.04K |
| Health Sciences Group | 20.51K |
| Regenicin | 15.35K |
| Biostax | 10.77K |
| Trevena | 10.64K |
| GeneLink | 10.60K |
| Navidea Biopharmaceuticals | 10.00K |